Glaxo Official Memo Urged Scientists to Withhold Information About Paxil's Risks, Trial Hears; Pharmaceutical Industry Today Offers Complete News Coverage
Glaxo Official Memo Urged Scientists to Withhold Information About Paxil's Risks, Trial Hears; Pharmaceutical Industry Today Offers Complete News Coverage
WASHINGTON, September 16 - /EIN Presswire/ Antidepressant drug Paxil, which generated about 2.1% of GlaxoSmithKline's total revenue last year, has been known to cause birth defects, but the world's second-biggest drugmaker hid its risks to pump up profits, a Philadelphia court has heard.
According to available information, Glaxo failed to properly test the drug and urged scientists to conceal Paxil's risks. The Philadelphia trial is the first of more than 600 cases against the London-based company.
Are you satisfied with the way your regular news sources report on these important stories? If not, try Pharmaceutical Industry Today (http://pharmaceuticals.einnews.com/), for free, to see what you may have been missing.
See:
-- GlaxoSmithKline News - http://pharmaceuticals.einnews.com/news/glaxosmithkline
-- Paxil News - http://pharmaceuticals.einnews.com/news/paxil
-- Latest Pharmaceutical News - http://pharmaceuticals.einnews.com/
For a free trial to Pharmaceutical Industry Today, go to: http://pharmaceuticals.einnews.com/users/register.php
About EIN Presswire - http://www.einpresswire.com
EIN Presswire is a news-syndication solution that distributes news to more than 10 million visitors annually at EIN News and millions more through its press release distribution partners. A news source for leading journalists, decision-makers and industry professionals worldwide, EIN Presswire targets press releases to a wide array of worldwide business professionals in more than 80 different industries. EIN Presswire also offers affiliate network opportunities and news distribution to tens of thousands of news subscribers daily. Read the newest business news at http://www.einpresswire.com and the latest world news in more than 80 different industries at http://www.einnews.com
Contact:
EIN News
press@einnews.com
Tel: +1 202 657 5158
Fax: +1 202 478 2767
http://www.einnews.com/
WASHINGTON, September 16 - /EIN Presswire/ Antidepressant drug Paxil, which generated about 2.1% of GlaxoSmithKline's total revenue last year, has been known to cause birth defects, but the world's second-biggest drugmaker hid its risks to pump up profits, a Philadelphia court has heard.
According to available information, Glaxo failed to properly test the drug and urged scientists to conceal Paxil's risks. The Philadelphia trial is the first of more than 600 cases against the London-based company.
Are you satisfied with the way your regular news sources report on these important stories? If not, try Pharmaceutical Industry Today (http://pharmaceuticals.einnews.com/), for free, to see what you may have been missing.
See:
-- GlaxoSmithKline News - http://pharmaceuticals.einnews.com/news/glaxosmithkline
-- Paxil News - http://pharmaceuticals.einnews.com/news/paxil
-- Latest Pharmaceutical News - http://pharmaceuticals.einnews.com/
For a free trial to Pharmaceutical Industry Today, go to: http://pharmaceuticals.einnews.com/users/register.php
About EIN Presswire - http://www.einpresswire.com
EIN Presswire is a news-syndication solution that distributes news to more than 10 million visitors annually at EIN News and millions more through its press release distribution partners. A news source for leading journalists, decision-makers and industry professionals worldwide, EIN Presswire targets press releases to a wide array of worldwide business professionals in more than 80 different industries. EIN Presswire also offers affiliate network opportunities and news distribution to tens of thousands of news subscribers daily. Read the newest business news at http://www.einpresswire.com and the latest world news in more than 80 different industries at http://www.einnews.com
Contact:
EIN News
press@einnews.com
Tel: +1 202 657 5158
Fax: +1 202 478 2767
http://www.einnews.com/
Follow us
What people say
“We have generated many, many press clippings and improved our SEO ranking from the services that EIN Presswire provides us. Easy and simple way to upload and distribute our press releases. I would recommend their services.”
— Chris Morris, Marketing Manager of Mountz Inc.
“I have been using the EIN Press Release service for more than three years in entertainment & health care industries. Their account managers and the placement of my press releases online has been above reproach reaching mainstream journalists to help further client and brand visibility. I highly recommend this service for global notoriety and am thankful I made that first call.“
— Monica Anders PR Strategist 25 Years!
Our Partners
Press releases
- Atlanta Airport Hotel Lets Guests Save 15% or More with The Great Getaway Offer [23 May 2012] 24-7 pressrelease
- AsiaRooms.com - Asia International Guitar Festival and Competition Returns to Bangkok [23 May 2012] 24-7 pressrelease
- Manufacturing in Mexico Events to be Hosted this Fall by The Offshore Group [23 May 2012] 24-7 pressrelease
- AsiaRooms.com - Celebrate Pineapple Nang Lae and Lin Chee Chiang Rai Festival in Thailand [23 May 2012] 24-7 pressrelease
- Cleanfinancial.com Creates New Guide to Speculating on Facebook Shares [23 May 2012] 24-7 pressrelease
© 2005-2012